TrialThe oncologist2012

U.S. Food and Drug Administration Approval: peginterferon-alfa-2b for the adjuvant treatment of patients with melanoma.

Thomas M Herndon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.